EVP, Head of US Oncology · INCYTE CORP · Common Stock
Side
SELL
Value
$1.18M
Shares
10.9K
Price
$109.07
Executed
Jan 7, 2026
Disclosed
Jan 8, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 7 executedJan 8, 2026 disclosed
INCY · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Issa Mohamed Khairie filed this Form 4 reporting a open-market sale of INCY on Jan 7, 2026. It became public on Jan 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Head of US Oncology
Issa Mohamed Khairiecik:0002050035
Issuer
INCYTE CORPcik:0000879169
Revision history · 0
No field has changed since this record was first ingested.
